United States · FDA National Drug Code directory
LIBTAYO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61755-008_024fbfcd-06aa-44d2-ae90-1aa59f65425c
- Product NDC
- 61755-008
- Form
- INJECTION
- Composition / generic term
- cemiplimab-rwlc
- Labeler
- Regeneron Pharmaceuticals, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20180928
- Source listing expiry
- 20271231
Source-listed ingredients
- CEMIPLIMAB — 50 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (61755-008-01) / 7 mL in 1 VIAL, SINGLE-USE · 61755-008-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →